Overview
The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)
Eligibility
Inclusion Criteria:
- Age 18 years or above
- Diagnosis of chronic migraine
- Referred for diagnostic cerebral angiography to screen for intracranial pathology
- Written informed consent able to be obtained from subject
Exclusion Criteria:
- Baseline HIT-6 score less than 50
- Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
- Concomitant intracranial pathology (eg, intracranial malignancy)
- Known hypersensitivity and/or contraindication to lidocaine or local anesthetics of the amide type
- Taking chronic medications that, when co-administered with lidocaine and other local anesthetics, are at increased risk of developing methemoglobinemia (nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, acetaminophen, metoclopramide, quinine, sulfasalazine)
- Known contraindications for angiography (eg, ESRD not requiring hemodialysis). Patients with contrast allergy with be premeditated with diphenhydramine and steroids.
- Contraindication to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC)
- Concurrent participation in another research protocol for investigation of an experimental therapy
- Per DSA imaging, presence of a cerebrovascular pathology known to cause headache (eg, arteriovenous malformation, dural arteriovenous fistula)
- Per DSA imaging, presence of anastomosis or anatomical variation (eg, branches of middle meningeal artery) that could lead to increased procedural risk
- Per DSA imaging, lack of endovascular access to either middle meningeal artery, or origin of the middle meningeal artery other than from the external carotid artery
- Known or suspected inability to adhere to study protocol or protocol requirements, as per discretion of the Investigator or treating provider


